NO147560C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater

Info

Publication number
NO147560C
NO147560C NO792474A NO792474A NO147560C NO 147560 C NO147560 C NO 147560C NO 792474 A NO792474 A NO 792474A NO 792474 A NO792474 A NO 792474A NO 147560 C NO147560 C NO 147560C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogy procedure
indanyl derivatives
indanyl
Prior art date
Application number
NO792474A
Other languages
English (en)
Norwegian (no)
Other versions
NO792474L (no
NO147560B (no
Inventor
Eberhard Schroeder
Clemens Rufer
Irmgard Boettcher
Joachim-Friedrich Kapp
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19782833202 external-priority patent/DE2833202A1/de
Priority claimed from DE19792923937 external-priority patent/DE2923937A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO792474L publication Critical patent/NO792474L/no
Publication of NO147560B publication Critical patent/NO147560B/no
Publication of NO147560C publication Critical patent/NO147560C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/35Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/36Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C07C205/38Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. nitrodiphenyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO792474A 1978-07-27 1979-07-26 Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater NO147560C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782833202 DE2833202A1 (de) 1978-07-27 1978-07-27 Neue indanyl- und tetralinylamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE19792923937 DE2923937A1 (de) 1979-06-11 1979-06-11 Neue indanyl-derivate, ihre herstellung und verwendung

Publications (3)

Publication Number Publication Date
NO792474L NO792474L (no) 1980-01-29
NO147560B NO147560B (no) 1983-01-24
NO147560C true NO147560C (no) 1983-05-04

Family

ID=25775214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792474A NO147560C (no) 1978-07-27 1979-07-26 Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater

Country Status (23)

Country Link
US (1) US4244960A (da)
EP (1) EP0009554B1 (da)
AU (1) AU532405B2 (da)
BG (1) BG36197A3 (da)
CA (1) CA1124724A (da)
DD (1) DD145101A5 (da)
DE (1) DE2965279D1 (da)
DK (1) DK159269C (da)
DZ (1) DZ206A1 (da)
EG (1) EG14394A (da)
ES (1) ES482918A1 (da)
FI (1) FI71306C (da)
FR (1) FR2433512A1 (da)
GB (1) GB2025973A (da)
GR (1) GR73006B (da)
IE (1) IE48783B1 (da)
IL (1) IL57901A (da)
NO (1) NO147560C (da)
NZ (1) NZ191100A (da)
PH (1) PH20604A (da)
PL (1) PL126816B1 (da)
PT (1) PT69986A (da)
RO (1) RO78632A (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3103372A1 (de) * 1981-01-27 1982-09-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung
DE3208079A1 (de) * 1982-03-04 1983-09-08 Schering AG, 1000 Berlin und 4709 Bergkamen Neue indanyl-derivate, ihre herstellung und verwendung
US4555406A (en) * 1983-09-06 1985-11-26 Schering Aktiengesellschaft Indanyl derivatives, their preparation and use
DE3343331A1 (de) * 1983-11-28 1985-06-05 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von indanyl-derivaten und deren verwendung
EP0305529A4 (en) * 1987-02-10 1990-04-10 Idemitsu Kosan Co TRIFLUORMETHANE SULPHONAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION AND WEED CONTROLS THAT CONTAIN THESE.
US5035739A (en) * 1987-02-10 1991-07-30 Idemitsu Kosan Company Limited Trifluoromethanesulfonamide derivative and a herbicide containing the same
JPH0753725B2 (ja) * 1987-10-08 1995-06-07 富山化学工業株式会社 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
GB9003551D0 (en) * 1990-02-16 1990-04-11 Ici Plc Heterocyclic compounds
US5604260A (en) * 1992-12-11 1997-02-18 Merck Frosst Canada Inc. 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
US5409944A (en) * 1993-03-12 1995-04-25 Merck Frosst Canada, Inc. Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
US5968958A (en) * 1995-01-31 1999-10-19 Merck Frosst Canada, Inc. 5-Methanesulfonamido-3H-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
ES2138902B1 (es) * 1997-05-19 2000-09-16 Salvat Lab Sa "5-ariltio-6-sulfonamido-3(2h)-benzofuranonas como inhibidores de la cox-2".
DE10142660A1 (de) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142722A1 (de) 2001-08-31 2003-03-27 Aventis Pharma Gmbh C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142662B4 (de) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142659A1 (de) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142668A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von C2-substituierten Indan-1-on-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142667B4 (de) 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142666A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921958A (en) * 1954-09-03 1960-01-19 Ruhrchemie Ag 4.5.6.7.10.10-hexachloro-4.7-methylene-4.7.8.9-tetrahydroindane-sulfonic acid, saltsand acid amides thereof
US3288852A (en) * 1964-05-08 1966-11-29 Dow Chemical Co Anthracene dialkanesulfonamides
AR206496A1 (es) * 1972-07-03 1976-07-30 Riker Laboratories Inc Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas
US4087549A (en) * 1972-12-06 1978-05-02 Merck & Co., Inc. Sulphonic acid containing indenyl derivatives
US4086255A (en) * 1974-04-15 1978-04-25 Minnesota Mining And Manufacturing Company Perfluoroalkylsulfonamidoaryl compounds
GB1472843A (en) * 1976-02-12 1977-05-11 Pfizer Ltd Benzene sulphonamides
PH13946A (en) * 1977-11-29 1980-11-04 Ishihara Sangyo Kaisha Sulfonanilide compounds and herbicidal compositions containing the same

Also Published As

Publication number Publication date
IE48783B1 (en) 1985-05-15
FR2433512A1 (fr) 1980-03-14
DK159269B (da) 1990-09-24
PT69986A (de) 1979-08-01
FI71306C (fi) 1986-12-19
FI792347A (fi) 1980-01-28
US4244960A (en) 1981-01-13
FI71306B (fi) 1986-09-09
AU4932579A (en) 1980-02-07
RO78632A (ro) 1982-04-12
ES482918A1 (es) 1980-05-16
EG14394A (en) 1983-12-31
EP0009554A1 (de) 1980-04-16
PL126816B1 (en) 1983-09-30
NO792474L (no) 1980-01-29
PH20604A (en) 1987-02-24
IL57901A (en) 1983-11-30
GR73006B (da) 1984-01-24
IL57901A0 (en) 1979-11-30
DE2965279D1 (en) 1983-06-01
BG36197A3 (en) 1984-09-14
EP0009554B1 (de) 1983-04-27
DK159269C (da) 1991-02-18
DK315979A (da) 1980-01-28
AU532405B2 (en) 1983-09-29
DD145101A5 (de) 1980-11-19
NO147560B (no) 1983-01-24
CA1124724A (en) 1982-06-01
DZ206A1 (fr) 2004-09-13
IE791422L (en) 1980-01-27
NZ191100A (en) 1982-03-30
GB2025973A (en) 1980-01-30
PL217384A1 (da) 1981-11-13

Similar Documents

Publication Publication Date Title
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO151622C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive carboxyalkyldipeptider
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO149662C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive c-076-forbindelser
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO792787L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO151546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidoner
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
NO149733C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin
NO149312C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 2-(2-tenoyltio)-propionylglycin
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO781824L (no) Fremgangsmaate ved fremstilling av analgesisk aktive forbindelser
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO151500C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater